Advisor Group Holdings, Inc. Day One Biopharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 32,881 shares of DAWN stock, worth $240,031. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,881
Previous 212
15409.91%
Holding current value
$240,031
Previous $1,000
21200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DAWN
# of Institutions
182Shares Held
70.6MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$46.9 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.1 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$29.9 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.2 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $536M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...